🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Evaluating the Impact of Using the B-OK Bottles for HIV and ART Literacy in South Africa

RecruitingNAAges 18 Years - anyAllUniversity of Pennsylvania
NCT07703891 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Consistent use of antiretroviral therapy (ART) is essential for achieving suppression among people with HIV (PWH). Yet despite improvements in access to ART and improving viral suppression rates, an estimated one-third of PWH globally do not take ART as prescribed, thus allowing the virus to remain detectable and transmissible. This study tests whether a low-cost visual education tool, B-OK bottles, improves understanding of HIV, antiretroviral therapy (ART), and the concept of Undetectable = Untransmittable (U=U) among adults in Gauteng, South Africa using a randomized trial. Participants will be randomly assigned to one of three groups: (1) standard-of-care verbal information based on Department of Health guidelines, (2) information delivered in person using B-OK bottles, or (3) information delivered via a video demonstrating the B-OK bottles. The study will compare the two interventio

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Aged 18 years or older * Residing in Gauteng * Able to understand and communicate in English or another study-supported language * Willing to attend an in-person study visit at the HE2RO offices * Willing to provide contact details for follow-up at six weeks Exclusion Criteria: * Unwilling or unable to provide written informed consent for study participation
💊

What it tests

  • B-OK Bead Bottles Intervention (delivered in person)
  • B-OK Bottles Intervention (delivered by video)
  • Control
📍

Where

1 site
Health Economics and Epidemiology Research Office (HE2RO), University of the Witwatersrand
Johannesburg, South Africa
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy